# EDGAR Filing Document

**Accession Number:** 0001840416
**File Stem:** 0001171843-25-004369
**Filing Date:** 2025-7
**Character Count:** 12570
**Document Hash:** e11161add5003d7de4f675ed1f5dfc7b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001171843-25-004369.hdr.sgml**: 20250708

**ACCESSION NUMBER**: 0001171843-25-004369

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20250706

**ITEM INFORMATION**: Entry into a Material Definitive Agreement

**ITEM INFORMATION**: Unregistered Sales of Equity Securities

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20250708

**DATE AS OF CHANGE**: 20250708

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Sono Group N.V.
- **CENTRAL INDEX KEY:** 0001840416
- **STANDARD INDUSTRIAL CLASSIFICATION:** SEMICONDUCTORS & RELATED DEVICES [3674]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 000000000
- **STATE OF INCORPORATION:** P7
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41066
- **FILM NUMBER:** 251111355

**BUSINESS ADDRESS:**
- **STREET 1:** WALDMEISTERSTRASSE 93
- **CITY:** MUNICH
- **STATE:** 2M
- **ZIP:** 80935
- **BUSINESS PHONE:** 49-89-45205818

**MAIL ADDRESS:**
- **STREET 1:** WALDMEISTERSTRASSE 93
- **CITY:** MUNICH
- **STATE:** 2M
- **ZIP:** 80935

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**__________________________**

**FORM 8-K**

**__________________________**

**CURRENT REPORT**

**PURSUANT TO SECTION 13 OR 15(D)** 

**OF THE SECURITIES EXCHANGE ACT OF 1934**

**Date of Report (Date of earliest event reported): July 6, 2025**

**__________________________**

**Sono Group N.V.** **(Exact name of registrant as specified in its charter)**

**__________________________**

---

| | | |
|:---|:---|:---|
| **The Netherlands**<br> (State or other jurisdiction<br> of incorporation) | **001-41066**<br> (Commission File Number) | **98-1828632**<br> (IRS Employer<br> Identification No.) |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Waldmeisterstrasse 93, Munich, Germany** | &nbsp;&nbsp; **80935** |
| (Address of principal executive offices) | (Zip Code) |

---

**+49 (0)89 4520 5818**

(Registrant's telephone number, including area code)

**__________________________**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Not Applicable | Not Applicable | Not Applicable |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 1.01 Entry into a Material Definitive Agreement.**

The information under Item 3.02 below is incorporated by reference into this Item 1.01.

**Item 3.02 Unregistered Sales of Equity Securities.**

As previously disclosed, Sono Group N.V. (the "Company") and YA II PN, Ltd. ("Yorkville"), entered into (i) a securities purchase agreement, dated December 30, 2024 (as amended, the "Securities Purchase Agreement"), pursuant to which the Company agreed to sell and issue to Yorkville a new convertible debenture (the "Debenture") in the aggregate principal amount of $5,000,000 and (ii) an exchange agreement, dated December 30, 2024 (as amended, the "Exchange Agreement"), pursuant to which the Company agreed to issue shares of preferred stock of the Company to Yorkville in exchange for the surrender and cancellation of all of the debentures held by Yorkville. The obligations of the parties under the Securities Purchase Agreement and the Exchange Agreement are subject to certain conditions and limitations, including the Company's receipt of notice from Nasdaq that the Company has met all the applicable requirements for listing of the Company's ordinary shares (the "Ordinary Shares") on the Nasdaq Capital Market. The Company and Yorkville subsequently entered into five Omnibus Amendments to Transaction Documents, respectively dated February 12, 2025 (the "First Omnibus Amendment"), March 7, 2025 (the "Second Omnibus Amendment"), March 25, 2025 (the "Third Omnibus Amendment"), April 24, 2025 (the "Fourth Omnibus Amendment") and May 26, 2025, pursuant to which the Company and Yorkville agreed to modify certain terms of the Securities Purchase Agreement and the Exchange Agreement.

On July 6, 2025, the Company and Yorkville entered into a sixth Omnibus Amendment to Transaction Documents, effective as of June 30, 2025 (the "New Omnibus Amendment"), pursuant to which the parties agreed to modify the terms of the Securities Purchase Agreement, the Exchange Agreement and certain convertible debentures previously issued by the Company.

Pursuant to the New Omnibus Amendment, the parties agreed to extend the maturity date from July 1, 2025 to August 1, 2025 for the four convertible debentures previously issued by the Company, including the (1) Convertible Debenture issued on December 7, 2022 in the original principal amount of $11.1 million ("Debenture SEV-1"), (2) Convertible Debenture issued on December 8, 2022 in the original principal amount of $10.0 million ("Debenture SEV-2"), (3) Convertible Debenture issued on December 20, 2022 in the original principal amount of $10.0 million ("Debenture SEV-3"), and (4) Convertible Debenture issued on February 5, 2024 in the original principal amount of $4,317,600 ("Debenture SEV-4," and collectively with Debenture SEV-1, Debenture SEV-2, and Debenture SEV-3, the "Maturing Debentures").

Pursuant to the New Omnibus Amendment, the parties also agreed to extend the termination dates of the Securities Purchase Agreement and the Exchange Agreement to August 1, 2025.

The foregoing description of the New Omnibus Amendment does not purport to be complete and is qualified in its entirety by the terms of the New Omnibus Amendment, which is attached hereto as Exhibit 10.1 and is incorporated herein by reference.

**Item 9.01. Financial Statements and Exhibits.**

(d) Exhibits. The following exhibit is filed with this Current Report on Form 8-K:

---

| | |
|:---|:---|
| <u>Exhibit</u> | <u>Description of Exhibit</u> |
| [10.1](exh_101.htm) | [Sixth Omnibus Amendment to Transaction Documents dated July 6, 2025](exh_101.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **Sono Group N.V.** | **Sono Group N.V.** |
| By | /s/ George O'Leary | /s/ George O'Leary |
|  | Name: | George O'Leary |
|  | Title: | Managing Director |

---

Date: July 8, 2025

## Exhibit 10.1

**Exhibit 10.1**

#### OMNIBUS AMENDMENT TO TRANSACTION DOCUMENTS
This Omnibus Amendment to Transaction Documents (this "<u>Amendment</u>" or "<u>Agreement</u>") is entered into on July 6, 2025 effective as of June 30, 2025 by and between Sono Group N.V., a Dutch public limited liability company (the "<u>Company</u>") and YA II PN, LTD., a Cayman Islands exempt limited partnership (the "<u>Investor</u>"), with reference to (1) the Exchange Agreement entered into on December 30, 2024 between the Company to the Investor ("<u>Exchange Agreement</u>"); (2) the Securities Purchase Agreement entered into on December 30, 2024 between the Company and the Investor (the "<u>Securities Purchase Agreement</u>"); (3) the Funding Commitment Letter entered into on November 17, 2023, as amended from time to time, between the Company and the Investor (the "<u>Funding Commitment Letter</u>");

**WHEREAS**, as of June 30, 2025, the Investor is the holder of the following convertible debentures (among others) that have a maturity date of July 1, 2025: (1) Convertible Debenture issued on December 7, 2022 in the original principal amount of $11.1 million ("<u>Debenture SEV-1</u>"), (2) Convertible Debenture issued on December 8, 2022 in the original principal amount of $10.0 million ("<u>Debenture SEV-2</u>"), (3) Convertible Debenture issued on December 20, 2022 in the original principal amount of $10.0 million ("<u>Debenture SEV-3</u>"), and (4) Convertible Debenture issued on February 5, 2024 in the original principal amount of $4,317,600 ("<u>Debenture SEV-4</u>," and collectively with Debenture SEV-1, Debenture SEV-2, and Debenture SEV-3, the "<u>Maturing Debentures</u>").

**WHEREAS**, in connection with the Company's efforts to satisfy all the applicable requirements for the listing of its Ordinary Shares on the Nasdaq Capital Market ("<u>Nasdaq</u>"), the Company has requested an extension to the deadline to satisfy the conditions set forth in the Exchange Agreement, and pursuant to the terms and conditions of this Amendment, the Investor agrees to such extension.

**WHEREAS,** pursuant to the Securities Purchase Agreement, the Investor shall have the right to terminate its obligation to purchase Convertible Debentures thereunder if the closing has not occurred by a certain date, and the Company has requested an extension to such date, and pursuant to the terms and conditions of this Amendment, the Investor agrees to such extension.

By this Amendment, the Company and Lender have agreed to the following terms:

&nbsp;&nbsp;&nbsp;&nbsp;1. <u>Modifications to the Securities Purchase Agreement, Exchange Agreement, and Maturing Debentures</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. The Investor agrees that the termination date with respect to the obligations of
the Investor under the Securities Purchase Agreement set forth in Section 8 thereof shall be extended August 1, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. The Investor agrees that the termination date with respect to the obligations
of the Investor under the Exchange Agreement set forth in Section 6 thereof shall be extended August 1, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. The Investor agrees that the Maturity Date of the Matured Debentures shall be extended
to August 1, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;2. **This Agreement One of the Transaction Documents**. From and after the date
hereof, this Agreement is and shall be deemed a "Transaction Document" as used in the Securities Purchase Agreement and the
Exchange Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;3. **Miscellaneous**. This Agreement shall be governed by and construed in accordance
with the laws of the State of New York. This Agreement may be executed in counterparts, each of which, when so executed, shall be deemed
an original, but all such counterparts, taken together, shall constitute one and the same instrument. Delivery of an executed counterpart
of this Agreement by telefacsimile or electronically shall be equally as effective as delivery of a manually executed counterpart of this
Agreement.

**IN WITNESS WHEREOF**, the Company and Investor have caused this this Omnibus Amendment to Transaction Documents to be duly executed by a duly authorized officer as of the date first written above.

#### COMPANY:
**SONO GROUP N.V.**

By: <u>/s/ George O'Leary</u>

Name: George O'Leary

Title: Chief Executive Officer and Managing Director

#### INVESTOR:
**YA II PN, LTD.**

By: Yorkville Advisors Global, LP

Its: Investment Manger

By: Yorkville Advisors Global II, LLC

Its: General Partner

By: <u>/s/ Michael Rosselli</u>

Name: Michael Rosselli

Title: Partner